ReAlta Life Sciences, Inc.
Norfolk, VA · Founded 2017 · CIK 0001752530 · Biotech · Private
PIC1 (Peptide Inhibitor of Complement C1), a 15 amino acid peptide conjugated with PEG that binds C1q to block classical complement pathway activation
realtalifesciences.com →- Grants
- $2.1M
- 2 awards
- Sector median: 1
- Raised
- $94M
- 7 Form D · May 2025
- 17 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 17
- 0 granted · 17 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $4,847,346 | |
| Federal grant | Department of Health and Human Services · Phase II · PIC1 pre-clinical formulation and optimization as a novel anti-inflammatory pharmacological agent | $1,497,741 | |
| Private capital raised | Form D · SEC | $12,000,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · PIC1 pre-clinical formulation and optimization as a novel anti-inflammatory pharmacological agent | $578,570 | |
| Private capital raised | Form D · SEC | $22,500,017 | |
| Private capital raised· 1 of 3 same day | Form D · SEC | $25,000,141 | |
| Private capital raised· 2 of 3 same day | Form D · SEC | $11,999,998 | |
| Private capital raised· 3 of 3 same day | Form D · SEC | $29,929,943 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2835 | Tango Therapeutics | — | $95M |
| 2836 | Arcutis Biotherapeutics, Inc. | — | $94M |
| 2837 | OMNI BIO PHARMACEUTICAL, INC. | — | $28M |
| 2838 | ReAlta Life Sciences, Inc. | — | $94M |
| 2839 | Verve Therapeutics | — | $94M |
| 2840 | Scorpion Therapeutics | — | $297M |
| 2841 | VASCULAR BIOSCIENCES, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Kathryn AbshireExecutive Officer
- Mert AktarDirector
- Kenji CunnionDirector · Executive Officer
- Frank GadamsDirector
- Deborah GeraghtyDirector
- Laurie GlimcherDirector
- John HardingDirector · Executive Officer
- Edward Heidt, Jr.Director · Executive Officer
- Neel KrishnaExecutive Officer
- David MarekDirector · Executive Officer
- Paolo MartiniExecutive Officer
- Thomas McCarterExecutive Officer
- Andrew MillerDirector
- Azmi NabulsiDirector
- Jerry NadlerDirector
- Christine NeikirkDirector
- Emma ReeveDirector
- John RickmanExecutive Officer
- Christi ShawDirector
- Barry StrasnickDirector
- Ulrich ThienelDirector · Executive Officer
- Lewis WilliamsDirector
- Jonathan ZalevskyDirector
Patents
- Peptides And Methods Of Useapplication
- Peptides And Methods Of Useapplication
- Peptide Formulations And Methods Of Useapplication
- Peptides And Methods Of Useapplication
- Peptides And Methods Of Useapplication
- Peptides And Methods Of Useapplication
- Peptides And Methods Of Useapplication
- Peptides And Methods Of Useapplication
- Peptides And Methods Of Useapplication
- Peptide Formulations And Methods Of Useapplication
- Peptides And Methods Of Useapplication
- Peptides And Methods Of Useapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.